Statin use and tooth loss in chronic periodontitis patients

J. Cunha-Cruz, B. Saver, G. Maupome, Philippe P. Hujoel

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Background: Statins have anti-inflammatory and bone stimulating properties that may positively affect chronic periodontitis. Our objective in this study was to evaluate whether statin use by chronic periodontitis patients had a beneficial impact on tooth loss. Methods: In a retrospective cohort study (N patients = 1,021; mean follow-up = 7.1 years), dental records were merged with pharmacy data. Any statin use during 3 years, statin use during each of 3 consecutive years (regular use), and any statin use during the first 3 years after the initial periodontal exam were evaluated as predictors of tooth loss using negative binomial regression models with adjustment for potential confounding factors. Results: Any statin use during 3 years was not associated with tooth loss rate in the year subsequent to the 3-year period (rate ratio [RR] = 1.00; 95% confidence interval [CI] = 0.56 to 1.81). Regular statin use during 3 years was associated with a non-significant 37% reduced tooth loss rate in the year subsequent to the 3-year period (RR = 0.63; 95% CI = 0.32 to 1.25). Any statin use during the first 3 years after the initial periodontal exam was associated with a 48% decreased tooth loss rate in year 4 and subsequent years (RR = 0.52; 95% CI = 0.29 to 0.95). Conclusions: Our findings were mixed for an association of statin use with reduced tooth loss in chronic periodontitis patients. Lack of control for some potential confounders, particularly smoking, and evaluation of different patterns of statin usage hamper the interpretation of the results. Exploration of these findings in additional epidemiological studies may be worthwhile.

Original languageEnglish (US)
Pages (from-to)1061-1066
Number of pages6
JournalJournal of periodontology
Volume77
Issue number6
DOIs
StatePublished - Jun 1 2006

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Tooth Loss
Chronic Periodontitis
Confidence Intervals
Dental Records
Statistical Models
Epidemiologic Studies
Cohort Studies
Anti-Inflammatory Agents
Retrospective Studies
Smoking

Keywords

  • Cohort studies
  • HMG CoA
  • Hydroxymethylglutaryl-CoA reductase inhibitors
  • Periodontal diseases
  • Periodontal diseases/drug therapy
  • Statins

ASJC Scopus subject areas

  • Periodontics

Cite this

Statin use and tooth loss in chronic periodontitis patients. / Cunha-Cruz, J.; Saver, B.; Maupome, G.; Hujoel, Philippe P.

In: Journal of periodontology, Vol. 77, No. 6, 01.06.2006, p. 1061-1066.

Research output: Contribution to journalArticle

Cunha-Cruz, J. ; Saver, B. ; Maupome, G. ; Hujoel, Philippe P. / Statin use and tooth loss in chronic periodontitis patients. In: Journal of periodontology. 2006 ; Vol. 77, No. 6. pp. 1061-1066.
@article{6cd321930b6343dc8e1cad4d31b06393,
title = "Statin use and tooth loss in chronic periodontitis patients",
abstract = "Background: Statins have anti-inflammatory and bone stimulating properties that may positively affect chronic periodontitis. Our objective in this study was to evaluate whether statin use by chronic periodontitis patients had a beneficial impact on tooth loss. Methods: In a retrospective cohort study (N patients = 1,021; mean follow-up = 7.1 years), dental records were merged with pharmacy data. Any statin use during 3 years, statin use during each of 3 consecutive years (regular use), and any statin use during the first 3 years after the initial periodontal exam were evaluated as predictors of tooth loss using negative binomial regression models with adjustment for potential confounding factors. Results: Any statin use during 3 years was not associated with tooth loss rate in the year subsequent to the 3-year period (rate ratio [RR] = 1.00; 95{\%} confidence interval [CI] = 0.56 to 1.81). Regular statin use during 3 years was associated with a non-significant 37{\%} reduced tooth loss rate in the year subsequent to the 3-year period (RR = 0.63; 95{\%} CI = 0.32 to 1.25). Any statin use during the first 3 years after the initial periodontal exam was associated with a 48{\%} decreased tooth loss rate in year 4 and subsequent years (RR = 0.52; 95{\%} CI = 0.29 to 0.95). Conclusions: Our findings were mixed for an association of statin use with reduced tooth loss in chronic periodontitis patients. Lack of control for some potential confounders, particularly smoking, and evaluation of different patterns of statin usage hamper the interpretation of the results. Exploration of these findings in additional epidemiological studies may be worthwhile.",
keywords = "Cohort studies, HMG CoA, Hydroxymethylglutaryl-CoA reductase inhibitors, Periodontal diseases, Periodontal diseases/drug therapy, Statins",
author = "J. Cunha-Cruz and B. Saver and G. Maupome and Hujoel, {Philippe P.}",
year = "2006",
month = "6",
day = "1",
doi = "10.1902/jop.2006.050280",
language = "English (US)",
volume = "77",
pages = "1061--1066",
journal = "Journal of Periodontology",
issn = "0022-3492",
publisher = "American Academy of Periodontology",
number = "6",

}

TY - JOUR

T1 - Statin use and tooth loss in chronic periodontitis patients

AU - Cunha-Cruz, J.

AU - Saver, B.

AU - Maupome, G.

AU - Hujoel, Philippe P.

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Background: Statins have anti-inflammatory and bone stimulating properties that may positively affect chronic periodontitis. Our objective in this study was to evaluate whether statin use by chronic periodontitis patients had a beneficial impact on tooth loss. Methods: In a retrospective cohort study (N patients = 1,021; mean follow-up = 7.1 years), dental records were merged with pharmacy data. Any statin use during 3 years, statin use during each of 3 consecutive years (regular use), and any statin use during the first 3 years after the initial periodontal exam were evaluated as predictors of tooth loss using negative binomial regression models with adjustment for potential confounding factors. Results: Any statin use during 3 years was not associated with tooth loss rate in the year subsequent to the 3-year period (rate ratio [RR] = 1.00; 95% confidence interval [CI] = 0.56 to 1.81). Regular statin use during 3 years was associated with a non-significant 37% reduced tooth loss rate in the year subsequent to the 3-year period (RR = 0.63; 95% CI = 0.32 to 1.25). Any statin use during the first 3 years after the initial periodontal exam was associated with a 48% decreased tooth loss rate in year 4 and subsequent years (RR = 0.52; 95% CI = 0.29 to 0.95). Conclusions: Our findings were mixed for an association of statin use with reduced tooth loss in chronic periodontitis patients. Lack of control for some potential confounders, particularly smoking, and evaluation of different patterns of statin usage hamper the interpretation of the results. Exploration of these findings in additional epidemiological studies may be worthwhile.

AB - Background: Statins have anti-inflammatory and bone stimulating properties that may positively affect chronic periodontitis. Our objective in this study was to evaluate whether statin use by chronic periodontitis patients had a beneficial impact on tooth loss. Methods: In a retrospective cohort study (N patients = 1,021; mean follow-up = 7.1 years), dental records were merged with pharmacy data. Any statin use during 3 years, statin use during each of 3 consecutive years (regular use), and any statin use during the first 3 years after the initial periodontal exam were evaluated as predictors of tooth loss using negative binomial regression models with adjustment for potential confounding factors. Results: Any statin use during 3 years was not associated with tooth loss rate in the year subsequent to the 3-year period (rate ratio [RR] = 1.00; 95% confidence interval [CI] = 0.56 to 1.81). Regular statin use during 3 years was associated with a non-significant 37% reduced tooth loss rate in the year subsequent to the 3-year period (RR = 0.63; 95% CI = 0.32 to 1.25). Any statin use during the first 3 years after the initial periodontal exam was associated with a 48% decreased tooth loss rate in year 4 and subsequent years (RR = 0.52; 95% CI = 0.29 to 0.95). Conclusions: Our findings were mixed for an association of statin use with reduced tooth loss in chronic periodontitis patients. Lack of control for some potential confounders, particularly smoking, and evaluation of different patterns of statin usage hamper the interpretation of the results. Exploration of these findings in additional epidemiological studies may be worthwhile.

KW - Cohort studies

KW - HMG CoA

KW - Hydroxymethylglutaryl-CoA reductase inhibitors

KW - Periodontal diseases

KW - Periodontal diseases/drug therapy

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=33747050145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747050145&partnerID=8YFLogxK

U2 - 10.1902/jop.2006.050280

DO - 10.1902/jop.2006.050280

M3 - Article

C2 - 16734582

AN - SCOPUS:33747050145

VL - 77

SP - 1061

EP - 1066

JO - Journal of Periodontology

JF - Journal of Periodontology

SN - 0022-3492

IS - 6

ER -